A new online dynamic nomogram based on the inflammation burden index to predict cardiac injury after antitumor therapy in lung cancer patients.
Source check: Source checked. Not independent scientific confirmation.
Finding: The primary article develops and internally validates a dynamic nomogram using machine-learning/statistical predictors for one-year cardiac injury risk after antitumor therapy in 1,386 lung-cancer patients. The reviewed source supports this bounded result; external generalization, causal effects, and sustained operational impact remain unestablished where the source reports retrospective or internal evaluation.
Technology: Machine-learning/statistical modeling identifies predictors and builds the online nomogram.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Machine-learning/statistical modeling identifies predictors and builds the online nomogram.
- Test and result
- Training and validation AUC values of 0.85 and 0.86 are reported for cardiac-injury prediction.
- Limitation / still unknown
- The retrospective cohort includes explicit internal validation and clinical-utility analyses.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s40959-025-00328-3
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.